36 | hypericinIBA
12/2022
-
09/2003 |
21 | Contrast MediaIBA
01/2021
-
02/2002 |
20 | fosbretabulin (combretastatin A4)IBA
03/2021
-
03/2005 |
9 | DNA (Deoxyribonucleic Acid)IBA
02/2023
-
01/2017 |
8 | Biomarkers (Surrogate Marker)IBA
01/2020
-
08/2010 |
8 | Ethanol (Ethyl Alcohol)IBA
01/2018
-
07/2007 |
7 | Therapeutic UsesIBA
03/2024
-
03/2005 |
7 | combretastatinIBA
01/2019
-
03/2005 |
6 | rheinIBA
01/2021
-
02/2016 |
6 | iodohydroxybenzylpindololIBA
05/2015
-
11/2011 |
5 | Iodine-131IBA
04/2021
-
12/2013 |
5 | GadoliniumIBA
12/2019
-
05/2005 |
5 | RadiopharmaceuticalsIBA
02/2016
-
01/2013 |
5 | triphenyltetrazoliumIBA
12/2015
-
02/2002 |
4 | LipidsIBA
02/2023
-
05/2006 |
4 | Indicators and Reagents (Reagents)IBA
01/2018
-
01/2008 |
4 | Gadolinium DTPA (Magnevist)FDA Link
06/2015
-
12/2004 |
4 | pamoic acidIBA
08/2013
-
03/2007 |
4 | N-acetylcochinol-O-phosphateIBA
01/2012
-
08/2010 |
3 | IodineIBA
12/2022
-
09/2011 |
3 | Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
04/2021
-
08/2013 |
3 | Phosphates (Orthophosphate)IBA
01/2021
-
01/2016 |
3 | AnthraquinonesIBA
11/2020
-
01/2016 |
3 | TubulinIBA
01/2020
-
01/2011 |
3 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2020
-
06/2013 |
3 | Trinitrotoluene (TNT)IBA
12/2015
-
11/2011 |
3 | Antineoplastic Agents (Antineoplastics)IBA
10/2015
-
04/2008 |
3 | CholesterolIBA
12/2013
-
07/2009 |
3 | Pentetic Acid (DTPA)FDA LinkGeneric
06/2013
-
11/2007 |
2 | Hematoxylin (Haematoxylon)IBA
01/2023
-
10/2010 |
2 | Eosine Yellowish-(YS) (Eosin)IBA
01/2023
-
10/2010 |
2 | phosphatidylethanolamineIBA
01/2022
-
01/2013 |
2 | Hydroxychloroquine (Plaquenil)FDA LinkGeneric
12/2020
-
01/2020 |
2 | gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA
01/2020
-
12/2019 |
2 | gadoterate meglumineIBA
01/2020
-
09/2011 |
2 | EnzymesIBA
09/2018
-
01/2017 |
2 | SolventsIBA
08/2018
-
05/2014 |
2 | Dihydrotachysterol (AT 10)IBA
08/2017
-
03/2009 |
2 | AcidsIBA
01/2016
-
07/2007 |
2 | protohypericinIBA
01/2016
-
09/2015 |
2 | Radioisotopes (Radionuclides)IBA
01/2016
-
07/2010 |
2 | dihydroxydianthroneIBA
11/2015
-
05/2014 |
2 | SolutionsIBA
10/2015
-
09/2011 |
2 | Apolipoprotein B-48IBA
08/2015
-
05/2015 |
2 | Herbal TeasIBA
08/2015
-
12/2013 |
2 | Lipoproteins (Lipoprotein)IBA
05/2015
-
04/2008 |
2 | Sodium CholateIBA
05/2015
-
05/2014 |
2 | microplasminIBA
08/2007
-
10/2004 |
2 | AlbuminsIBA
08/2005
-
05/2005 |
1 | RNA (Ribonucleic Acid)IBA
02/2023 |
1 | Proteins (Proteins, Gene)FDA Link
02/2023 |
1 | NAD (NADH)IBA
01/2023 |
1 | Cyclin CIBA
01/2023 |
1 | NADH Tetrazolium ReductaseIBA
01/2023 |
1 | Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 |
1 | vascular disrupting agent C118PIBA
01/2023 |
1 | Oxytocin (Pitocin)FDA LinkGeneric
01/2023 |
1 | Thimerosal (Thiomersal)IBA
01/2023 |
1 | Auranofin (Ridaura)FDA Link
01/2023 |
1 | Thioredoxin Reductase 1IBA
01/2023 |
1 | Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric
12/2022 |
1 | Lipid Bilayers (Lipid Bilayer)IBA
01/2022 |
1 | 4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
01/2022 |
1 | CyclodextrinsIBA
04/2021 |
1 | Excipients (Suspending Agents)IBA
04/2021 |
1 | ginsenoside RdIBA
03/2021 |
1 | technetium Tc 99m glucarateIBA
01/2021 |
1 | AlkanesIBA
01/2021 |